Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00086229 · ClinicalTrials.gov registry record · NA
Absorption and Distribution of Glucosamine and Chondroitin
A NA study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT00086229 is a NA study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 70 participants.
The verdict
NCT00086229, a NA study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the way the dietary supplements glucosamine and chondroitin are absorbed and distributed throughout the body.
Interventions
- DRUG Chondroitin
- DRUG Glucosamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2004-04 |
| Est. Completion | 2006-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00086229
The ClinicalTrials.gov registry entry for NCT00086229 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chondroitin is the first listed.
NCT00086229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00086229 about?
NCT00086229 is a clinical study titled "Absorption and Distribution of Glucosamine and Chondroitin". The purpose of this study is to examine the way the dietary supplements glucosamine and chondroitin are absorbed and distributed throughout the body.
What is the current status of trial NCT00086229?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2004-04. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00086229?
The interventions under investigation include: Chondroitin (DRUG), Glucosamine (DRUG).
Who is sponsoring clinical trial NCT00086229?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.